Ming Fai International Holdings Limited (3828.HK): Deep Dive

Reporting periods used. Ming Fai's financial year ends on 31 December and it reports half-yearly, with voluntary unaudited updates for the first quarter and the first nine months. Hong Kong rules require interim results within two months of the half-year end, so the most recent release, for the six months to 30 June 2026, was due by late August 2026. The company's investor-relations page shows it was released on 25 August 2026, after a profit warning on 11 August 2026. Ming Fai holds no earnings calls. The six results events used here are the annual and interim announcements and reports:

• FY2023 annual results (March 2024)
• 1H2024 interim results (27 August 2024)
• FY2024 annual results (March 2025), preceded by a positive profit alert on 7 March 2025
• 1H2025 interim results (25 August 2025)
• FY2025 annual results (26 March 2026), preceded by a profit warning in mid-March 2026
• 1H2026 interim results (25 August 2026), preceded by the 11 August 2026 profit warning

They are supplemented by the voluntary quarterly updates of November 2024, November 2025 and 8 May 2026.

1. What the Company Does

Ming Fai makes the small things a hotel guest uses and throws away, and increasingly sells the bigger things a hotel needs to open its doors. If you have stayed in an Asian full-service hotel or flown long-haul in business class, you have probably used something it made: the shampoo and body-wash bottles, the wrapped soap, the toothbrush kit, the shower cap, the slippers, the sewing kit and the printed box they come in. It manufactures these to a hotel chain's or airline's specification, often under the customer's own brand, and ships them to properties in more than 80 countries. The company says its products reach more than 100 million guests a year across 73-plus hotel and airline brands.

Two smaller businesses sit alongside this core. One is a trading arm that sources and supplies "operating supplies and equipment" (OS&E) for new and renovating hotels: cutlery, crockery, kitchenware, linens, in-room kettles and coffee machines, lobby fittings and outdoor furniture. Much of it is third-party branded, from partners such as Philips, Nespresso, WMF, Cambro and Dometic. The other is a health care and hygienic products business, which sells almost entirely into North America and was born out of pandemic demand.

How it got here. The group was founded in Hong Kong in 1980. A Chinese-language corporate profile says it began by making shower caps. The company's website names Ching Chi Fai, the current chairman, as "a founder of the Group", and describes his younger brother Ching Chi Keung as having joined "with the founders", so the founding group was larger than one person. In 1986 it opened a factory in Pinghu, Shenzhen, which is still its main mainland production base. The milestones that shaped today's business followed in sequence:

• 1994: printing equipment, bringing packaging in-house.
• 1996: an in-house cosmetic laboratory, so it could formulate liquids rather than just fill them.
• 1998 to 2004: sales offices in Beijing, Shanghai, Dalian and Singapore, turning a Hong Kong exporter into a supplier to China's hotel boom.
• 2007: listing on the Hong Kong main board. A rival's disclosure documents later called it China's first listed hotel-supplies maker.

Then came a decade of diversification that did not work. In 2010 Ming Fai bought All Team Group and moved into cosmetics and fashion-accessory retail. It took Lanvin distribution rights for Asia-Pacific in 2012, set up a linen and towel plant in Guangxi in 2009 and a hotel laundry in Changshu in 2010. The laundry was terminated in 2014. In 2016 the company put its main investment property up for tender. The late Hong Kong activist investor David Webb, then holding about 10%, publicly argued that the company was "overcapitalised" with "a proven track record of losing money in new non-core businesses", and pushed for the proceeds to be returned as a special dividend. That episode explains why Webb's estate is today the second-largest shareholder (Section 10), and why any talk of "new business opportunities" deserves scrutiny (Section 8).

The modern shape came from two later decisions. In 2018 Ming Fai built a large plant in Kampong Speu, Cambodia, about an hour west of Phnom Penh, on a site the company gives as 130,240 square metres. In 2019 it created H-Square Hospitality Total Solution as the vehicle for the OS&E business, pitching itself to hotel developers as a one-stop shop. A 2023 Chinese trade-press profile summed up the ambition as being "the IKEA of the hotel industry". The pandemic briefly turned the group into a hygiene-products maker as travel collapsed. Since 2025, US tariffs on Chinese goods have pushed it to move production for its North American customers from China to Cambodia.

The value proposition. A global hotel chain wants every room in every country to carry the same branded amenity set, made to the same formula, passing the same safety and labour audits, delivered on time to properties from Shanghai to Sydney. Hotels spend relatively little per room on these items. One Chinese industry piece puts guest-room consumables at 3-6% of room cost. But amenities show up disproportionately in guest reviews. The buyer is therefore paying for reliability, compliance and breadth, not for a better shampoo. Ming Fai solves a procurement problem: one vetted vendor that can formulate, fill, package, print and ship a full amenity programme, and increasingly fit out the rest of the room too.

What makes it hard to replicate. Shampoo is not difficult to make. Making a hotel brand's own-label range to cosmetic-grade standards is harder: it means passing the customer's and the regulators' audits on three continents, keeping the product consistent across tens of millions of units, and running packaging, printing and filling under one roof. Section 3 covers these capabilities. Even so, the barriers are moderate, and a Chinese competitor's own listing documents state flatly that the category has no technical barriers.

A concrete example. A new 400-room international-brand hotel opening in a Chinese provincial city illustrates both halves. Through H-Square, Ming Fai can quote the opening order for the OS&E: restaurant crockery and cutlery, kitchen equipment, room kettles, coffee machines and linens, sourced from partner brands and consolidated into one delivery. Once the hotel opens, the recurring business starts. The property orders, or the chain's regional procurement team contracts for, the brand-standard amenity set. Ming Fai formulates the liquids in its lab to the brand's specification, fills and caps them in Shenzhen or Cambodia, prints the cartons, packs dental and vanity kits, and replenishes the hotel every few weeks for as long as it keeps the contract. The opening order is lumpy and low-margin trading. The replenishment is a manufacturing annuity.

2. Business Segments

Ming Fai reports three segments. Hospitality supplies is the business; the other two are a trading adjunct and a single-customer-type export line.

Hospitality Supplies

What it does. This segment makes guest-room amenities for hotels and in-flight amenities for airlines and travel retail. The products are liquids (shampoo, conditioner, shower gel, body lotion), solid soap, dental kits, razors, combs, shower caps, vanity and sewing kits, slippers, laundry bags and travel pouches, plus the bottles, tubes, cartons and printing that dress them in a customer's brand. Customers range from international chains and luxury independents to airlines. Corporate profiles cite long-running relationships with Shangri-La, Sheraton and Marriott properties, Cathay Pacific, Lufthansa, Qantas and Las Vegas Sands (Section 4 covers how they buy). The segment also supplies premium licensed ranges: the company has marketed hotel collections of names such as Molton Brown, AHAVA and Lanvin.

Core capability. The capability that counts is not chemistry but integrated execution: in-house formulation, packaging manufacture, printing, filling and kitting, carried out to cosmetic-grade quality and inside the labour and social-compliance audit regimes that global brands impose on their supply chains. Running that across two countries for more than 70 brands at once is the hard part.

Why it is a separate segment. It is the only one built on manufacturing, recurring replenishment orders and brand-standard approval.

Fit in the group. It is the cash and earnings engine. Every outlook statement in the last six results announcements leads with it, and every profit warning in the period was explained by its gross margin. The mix slipped in 1H2026 only because the other two segments grew faster, not because this one shrank.

Main rivals: ADA Cosmetics, Gilchrist & Soames, Guest Supply (Sysco), Groupe GM, and a long tail of Chinese makers including Jiangsu Opei.

Operating Supplies and Equipment (OS&E)

What it does. This is a trading and project-supply business run through the H-Square subsidiary set up in 2019. It supplies hotel developers, owners and pre-opening teams with the non-structural fit-out: tableware, kitchen and catering equipment, linens and bedding, guest-room appliances, cleaning supplies, lobby items and outdoor furniture, much of it under partner brands. About 77% of its 1H2026 revenue was in mainland China. It also runs showrooms, including one in Phnom Penh, where hotel buyers can specify a whole property.

Core capability. The capability is curation and project logistics: knowing what a given brand standard requires, aggregating hundreds of suppliers into one quote and delivery, and using existing relationships with hotel procurement teams from the amenity business to win the opening order.

Why it is separate. It makes nothing. Its economics are those of a distributor, its revenue is tied to hotel openings and renovations rather than occupied room-nights, and its customer is the developer or pre-opening team rather than the operating hotel.

Fit in the group. It is the growth adjunct. Management linked its 2025 growth to the recovery of hotel construction in China and named it as the segment that partly offset weakness elsewhere in late 2025. Its share of the mix has risen in each of the last three reported periods.

Main rivals: fragmented regional OS&E distributors and procurement agents in China and Southeast Asia, mostly private.

Health Care and Hygienic Products

What it does. This segment makes health care and hygiene products, and in 1H2026 sent about 96.6% of them to North America. The filings available for this report describe the line only at that level of generality. The 2025 interim report attributed that year's decline to falling demand for "anti-epidemic products", which places its origin in the 2020 pandemic pivot, when the hospitality business stalled. The Shenzhen base holds ISO 13485, the quality standard for medical devices, which is consistent with regulated hygiene products.

Core capability. It reuses the group's mass-manufacturing, compliance and US-export infrastructure. The near-total North American concentration, and the fact that production moved in 2025 at a customer's request, point to a small number of large buyers (Section 4).

Why it is separate. It has different end-markets, different regulation and different demand drivers from hotel amenities.

Fit in the group. It is a volatile, concentrated line. It shrank sharply in 2025 when the customer-driven move from China to Cambodia disrupted output (Section 3), then rebounded strongly in 1H2026 as Cambodian output ramped. Management does not describe it as a strategic priority.

Main rivals: not identifiable from the disclosures read for this report.

Geographic mix

Ming Fai has always been an exporter out of Hong Kong and southern China, so its geographic mix reflects decades of following the hotel chains it serves.

• Mainland China is the largest single market, at roughly 27% of group revenue in 1H2026. Its share has drifted down from about 29% in 1H2025 and 28% in FY2025. The company built its China network from 1998 to 2004 and rode the domestic hotel boom. China also carries most of the OS&E business. It is the market where amenity regulation has bitten hardest (Section 6), and Chinese trade-press figures show Ming Fai's China revenue fell by more than 40% between 2019 and 2022.
• North America accounts for roughly 18-20% of group revenue. It is two different businesses. In hospitality supplies it is a mid-sized export market (13.5% of that segment in 1H2026). In health care it is almost the entire segment. It is the region most exposed to US tariff policy, which is why North American production has been moved to Cambodia.
• Hong Kong is 21.3% of the hospitality segment, large relative to the city's size. It is home to the head office, several long-standing airline and hotel-group accounts and some regional procurement functions. Some of this revenue probably serves properties outside Hong Kong, though the filings do not say how much.
• Europe is 14.7% of the hospitality segment, mostly own-label work for chains and airlines.
• Other Asia-Pacific is 19.3% of the hospitality segment. It covers the Singapore office (opened 2004) and, increasingly, Southeast Asia served from Cambodia.
• Australia is 5.5% of the hospitality segment, served through a sales office opened in 2008.

3. Products and Operations

The products that matter

Liquid amenities are the heart of the business and its main value-add. These are shampoo, conditioner, shower gel, body lotion and hand wash, sold in single-use miniatures (typically 30-50ml) and, increasingly, in larger refillable or pump bottles and wall-mounted dispensers. Ming Fai formulates in-house, a capability it has had since the 1996 cosmetic laboratory, which lets it reproduce a brand's signature scent and texture and reformulate to meet ingredient rules across markets. The certifications listed for the Shenzhen base include GMPC (cosmetic good manufacturing practice, in both European and US versions), ECOCERT and the EU Ecolabel, which hotel brands increasingly ask for in their amenity tenders.

Solid amenities cover wrapped soaps, which are largely commoditised, and the growing category of shampoo and conditioner bars that substitute for bottles.

Dry amenities and kits include toothbrushes and toothpaste, razors, combs, shower caps, cotton buds, sewing and vanity kits, slippers, and laundry and shoe bags. These are low-cost items where the value lies in kitting, packaging and on-time delivery to many properties. The Cambodia plant alone has quoted monthly capacity above 1.5 million pairs of slippers and above 1.1 million bags and travel pouches.

Airline amenity kits are pouches combining dental, eye-mask, socks and skincare items, often co-branded with a luxury name and designed for business and first class. Airlines were among the group's earliest customers, and in-flight is still part of the hospitality segment.

Packaging and printing are internal capabilities since 1994: bottles, tubes, cartons and branded printing. They give Ming Fai control over lead times and brand presentation that a pure filler lacks.

Sustainable formats are the product line that matters most for the next decade. These are refillable dispensers, larger bottles, bars, biodegradable materials and FSC-certified packaging. Corporate profiles reference eco-product lines under names such as PSM, REECO and ECM. Section 6 explains why the single-use miniature is being regulated away. Ming Fai's ability to make the replacement formats determines whether that shift costs it units or simply changes the mix.

OS&E catalogue is the traded range described in Section 2: hundreds of SKUs from partner brands, not made by Ming Fai.

Where and how products are made

The company says it has three production bases. Its "About Us" page lists manufacturing in Shenzhen, Hong Kong SAR, Luoding (Guangdong) and Cambodia.

Pinghu, Shenzhen (since 1986). This is the historic main plant, described in a Chinese corporate profile as about 120,000 square metres. Formulation, filling, packaging manufacture and printing were consolidated here in 2003. It holds ISO 9001 (quality), ISO 14001 (environment), ISO 13485 (medical devices), GMPC, ECOCERT, the EU Ecolabel, C-TPAT (US customs supply-chain security) and China's environmental label.

Kampong Speu, Cambodia (since 2018). This is Ming Fai Enterprise (Cambodia) on National Road 41, a 17-block complex with 24 production lines. Its audit and certification set is the profile of a plant built to supply large Western buyers: ILO-related labour programmes, SMETA, Amfori BSCI, Disney's Facility and Merchandise Authorization, Walmart's audit assessment, FSC and the Higg Index. A 2021 local press report put the workforce at about 2,000, with plans to grow towards 5,000. The group as a whole employs about 7,800 people.

Luoding, Guangdong is listed as a base on the company's website. No detail on it was found in the sources reviewed.

The process, in simplified order:

1. Brand brief and formulation: the in-house lab matches the scent, texture and ingredient constraints.
2. Regulatory and customer approval: safety testing and brand sign-off.
3. Packaging manufacture and printing: bottles, tubes, cartons.
4. Filling, capping and labelling.
5. Kitting: dental, vanity and airline kits.
6. Quality control against the customer's specification.
7. Consolidated shipping to properties or regional warehouses.
8. Recurring replenishment.

The constraints are labour (kitting is labour-intensive), petrochemical inputs (plastic resin and surfactants) and freight, which is a large share of delivered cost for bulky, low-value goods.

Recent plant events: the Cambodia shift

The defining operational event of the last two years was the forced relocation of production for North America. In the November 2025 business update, management said the health care segment's revenue fell because of "operational disruption caused by customers requesting the relocation of certain production facilities from China to Cambodia in response to US tariff policy". The 2026 interim report then made Cambodia an explicit strategy for the hospitality segment as well: to allocate orders strategically to the Cambodian base "to leverage its geographic location and logistics advantages". The health care rebound in 1H2026 suggests the transferred lines are now producing.

What this means operationally:

• For a period the group ran two plants making overlapping products, with duplicated overheads and ramp-up inefficiency in Cambodia.
• Cambodia gives a lower-tariff origin for US-bound goods and a base close to Southeast Asian hotel markets.
• Some raw materials and components still come from China. That leaves the group exposed to rules-of-origin scrutiny if the US tightens its stance on goods made in Southeast Asia with Chinese inputs (Section 8).

The 1H2026 announcement also blamed higher manufacturing costs. Commentary on the period cited a Middle East conflict that pushed up oil prices, and with them the cost of plastic resin and logistics. The gross margin of the hospitality segment fell sharply in that half.

4. Customers

Who buys

Ming Fai has five broad customer types:

• International hotel chains, buying under group procurement agreements for a brand-standard amenity programme. Named relationships in corporate profiles include Shangri-La, Marriott and Sheraton properties.
• Individual hotels and regional groups, especially in mainland China, Hong Kong and Southeast Asia, often buying Ming Fai's own or licensed ranges.
• Airlines: Cathay Pacific, Lufthansa and Qantas are cited, buying in-flight amenity kits and lavatory products.
• Hotel developers and pre-opening teams, buying OS&E.
• North American buyers of health care and hygiene products. These are not named. The Cambodia plant's Walmart and Disney audit credentials are consistent with supplying large US retail or merchandise customers, but no filing read for this report names the health care customers.

How buying decisions are made

Chains. Amenities are specified by the brand team (brand standards, design and fragrance) and contracted by global or regional procurement. The criteria are, roughly in order:

1. Fidelity to the brand standard.
2. Compliance: product safety, ingredient rules and labour audits.
3. Ability to deliver consistently to properties in many countries.
4. Price per room-night.
5. Increasingly, sustainability credentials, including refillable formats and certified packaging.

Tenders typically run for months, with sampling and approval rounds. Once a supplier is on a chain's approved-vendor list for a brand in a region, individual hotels order against it.

Independent hotels. The general manager or purchasing manager decides, and price and range dominate. Sales cycles are short and switching is easy.

Airlines. Inflight-services teams buy through formal tenders, often with luxury co-branding and design competitions, on cycles of one to three years. These are prestige contracts where design and kit innovation matter.

OS&E. The developer's or operator's pre-opening team buys, mostly once per property, about 12-18 months before opening. Price and the ability to deliver a complete, brand-compliant package on schedule decide it.

Health care. The decision sits with the customer's sourcing function, and the 2025 relocation shows how much power that customer holds: it was the customer, not Ming Fai, that asked for production to move.

Why customers choose Ming Fai

• Breadth from one vendor. It can supply liquids, kits, packaging and the fit-out, which reduces the number of vendors a chain must audit.
• Track record. More than four decades with Asian full-service hotels and airlines.
• Compliance stack. GMPC, ISO 13485, ECOCERT and the EU Ecolabel in China, plus SMETA, BSCI and Disney and Walmart audits in Cambodia.
• Choice of manufacturing origin. Since 2025 it can produce outside China, which matters to US-bound business.
• In-house formulation and printing. Faster brand customisation than a pure filler.

Switching costs

Switching costs are real but modest.

• For a chain, changing amenity supplier means re-tendering, re-approving the formula and packaging, re-auditing a plant and managing the changeover across hundreds of properties. That is enough friction to make relationships last for years. But nothing prevents a chain from moving a brand's programme at the next tender, and many chains split brands or regions among suppliers.
• For an independent hotel, switching is close to free.
• For airlines, there is a defined re-tender point every contract cycle.
• OS&E has no lock-in at all: each property is a new sale.
• The health care customer evidently values continuity, since it moved production with Ming Fai rather than away from it. But it also dictated where that production would be.

Concentration

The filings reviewed for this report did not yield the top-customer percentages that Hong Kong annual reports disclose, so this report does not state them. Two structural observations hold anyway:

1. Hospitality supplies is spread across 73-plus brands and 80-plus countries, so no single property matters. But the global hotel industry is consolidated into a handful of parent companies, so the effective concentration at the parent level is higher than the brand count suggests.
2. The health care segment is almost certainly concentrated. It sells about 97% into one region, its output collapsed and recovered in step with a single customer-driven relocation, and the business is small enough to depend on a few accounts.

Contract structure and revenue predictability

There are three revenue streams:

• Replenishment orders (hospitality supplies) are recurring and track occupied room-nights. Prices are set at contract or tender and re-negotiated periodically. This is the most predictable stream, but it sits on top of hotel occupancy and is re-priced in competitive tenders.
• OS&E is project revenue that follows hotel openings and renovations. It is lumpy and dependent on the pipeline.
• Health care is order-driven export revenue whose level depends on the customer's needs and the customer's own tariff-driven sourcing decisions.

Overall, the business is more recurring than a project shop, but less locked-in than its long customer list suggests.

5. Competitive Landscape and Moat

How the industry is structured

Hotel amenities form a three-tier market.

The top tier consists of luxury cosmetic houses whose own brands appear in five-star bathrooms: L'Occitane, Le Labo, Diptyque and Bulgari, plus Asian entrants such as POLA's hotel line. Chinese trade coverage describes these houses increasingly partnering directly with luxury hotels as a consumer-marketing channel. They often contract out manufacturing, sometimes to firms like Ming Fai, which is why Ming Fai has carried licensed ranges such as Molton Brown, AHAVA and Lanvin.

The middle tier is where Ming Fai sits: specialist amenity manufacturers serving chains and airlines with own-label, licensed and house brands across many countries. This tier is a small club of mostly private, mostly family-owned or private-equity-owned companies, each strongest in its home region:

• ADA Cosmetics: Germany and Europe.
• Gilchrist & Soames: US luxury and upscale.
• Groupe GM: France and Europe.
• Hunter Amenities: Canada, with an Indian venture now branded Kimirica Hunter.
• Guest Supply: the US distributor-manufacturer owned by Sysco, dominant in North American mid-scale chains.
• Ming Fai: the Asian member of the club.

The bottom tier is a huge base of Chinese manufacturers, clustered around Yangzhou in Jiangsu and the Pearl River Delta, that make commodity amenities for economy hotels and, increasingly, export. Chinese industry coverage estimates that more than 98% of domestic hotel-supplies makers are small or medium-sized. Jiangsu Opei is a larger example: a Jiangsu maker that grew revenue strongly in 2024, sells about 60% abroad to North America, Europe and Oceania, partners with Kao on hotel-only lines, and delisted from China's NEEQ board in August 2025.

Competitor comparison

Where Ming Fai wins and loses

Against the Western specialists (ADA, Gilchrist & Soames, Groupe GM). Ming Fai wins on cost and on proximity to Asian chains and airlines. It loses in Western luxury, where brand teams in the US and Europe prefer suppliers on their own continent and where licensed luxury portfolios matter more. Europe and North America together are less than 30% of its hospitality revenue, which reflects that ceiling.

Against Guest Supply. Ming Fai rarely meets Sysco's unit head-on outside North America. Inside North America, Guest Supply's distribution reach and housekeeping catalogue give it a structural lead with mid-scale chains. Ming Fai's US hospitality share is a niche.

Against Chinese mass producers. This is where the margin pressure comes from. Every results event since 1H2025 has cited "intense industry competition", and the 1H2026 profit warning named it alongside manufacturing costs. In the economy and mid-scale segments, a hotel can buy adequate soap and shampoo from dozens of Chinese makers. Ming Fai's defence is its compliance stack, its formulation capability and the cost of switching chain-wide programmes. Those protect the international-chain and airline accounts, not the independent Chinese hotel.

Against luxury cosmetic houses. It is partly a competitor and partly a supplier. When a hotel chooses a luxury brand, Ming Fai may still make or distribute it, as with the licensed ranges above, but it captures less of the value.

OS&E. Ming Fai's edge is cross-selling from its amenity relationships. The competition is fragmented local distributors, so share depends on relationships and project execution, not scale.

Barriers to entry

• Commodity tier: very low. Jiangsu Opei's own listing documents state that the products have "no technical barriers" and that many firms can make substitutes, especially at the low end.
• Chain and airline tier: moderate. A newcomer needs years of audits, cosmetic-grade certifications, a multi-country logistics record and the trust of brand teams that cannot afford a product-safety incident across hundreds of hotels. Capital is not the barrier; references and track record are.
• OS&E: low.

Market share

No credible public estimate of global amenity market share exists, and the market-size estimates themselves vary widely (Section 6). Corporate profiles describe Ming Fai as one of the largest suppliers in Asia, and a Chinese competitor called it "one of the world's largest suppliers and manufacturers". The plausible picture is a fragmented global market in which Ming Fai is among the larger specialists in Asia-Pacific and a small player in Western markets. Shares are fragmented because the products are cheap to make, regional distribution matters and chains deliberately multi-source.

Structural shifts

1. Format change. Chains moving from single-use miniatures to bulk dispensers reduce the number of units and the packaging value per room, but raise the importance of dispenser systems and refill logistics. Specialists that invested early in those, such as ADA in Europe, gain ground.
2. Supply-chain relocation. US tariffs push US-bound production out of China. Ming Fai's Cambodian plant turns this into an advantage over Chinese-only rivals, but not over Western specialists with domestic plants.
3. Chinese export push. Mid-sized Chinese makers such as Opei are growing abroad, competing on price in the same export markets.
4. Brand-led luxury. Cosmetic houses are going direct to luxury hotels.

Moat: Narrow - regulatory or qualification barriers, scale / cost advantage

The advantage is real but thin. Global chains and airlines have kept Ming Fai on approved-vendor lists for decades, through the pandemic collapse and recovery. Its audited manufacturing base in two countries, its in-house formulation and its breadth across 70-plus brands are hard for a small rival to assemble quickly (Section 4). But the advantage has not translated into pricing power: in every half since early 2025, management has blamed competition and costs for a narrower margin, which means rivals are winning on price at the margin. What is most likely to erode the moat is the shift from miniatures to bulk dispensers. It turns a formulation-and-kitting business, where Ming Fai is strong, into a refill-logistics business with fewer units per room, where its advantages are less obvious.

6. Industry

What drives demand

Amenity demand is, at bottom, a function of occupied hotel room-nights multiplied by amenity spend per room-night, plus airline premium-cabin passengers. Four forces move those terms:

1. Travel volumes. Global tourism and business travel drive occupancy. The 2023-2024 recovery from the pandemic lifted the whole category, and Ming Fai's FY2023 and FY2024 results attributed their growth to recovering demand from tourism, sightseeing and aviation.
2. Hotel supply growth. New hotel openings, especially in China, India, the Middle East and Southeast Asia, add rooms that need both an opening fit-out (OS&E) and recurring amenities. China's commerce ministry and eight other departments issued guidance on high-quality development of the accommodation industry in October 2025, which signals continued policy support for hotel upgrading.
3. Mix upgrade. Brand standards at mid-scale and upscale hotels raise amenity spend per room. Chinese coverage argues that many nominally upscale Chinese hotels still under-spend on amenities, which suggests room for upgrading but also shows how price-sensitive buyers are.
4. Sustainability regulation and chain policy. This is now the force that most changes the product rather than the volume (below).

Industry size and growth

Published estimates disagree widely, which itself tells you how fragmented and poorly measured the category is:

• Ken Research put the global hotel toiletries market at about US$27bn in 2025, growing about 11% a year to 2031.
• Verified Market Reports put the broader hotel amenity market at about US$18bn in 2024, growing about 11% a year to 2032.

Both are low-transparency commercial estimates. The reasonable reading is a market in the tens of billions of dollars that grows with travel plus some upgrading, closer to mid-single-digit growth in real terms than the double digits these reports project, especially as unit volumes per room fall. North America is regarded as the largest regional market because of its large branded room base and centralised chain procurement.

Where Ming Fai sits in the supply chain

The supply chain runs:

1. Petrochemical and chemical inputs: resins, surfactants and fragrances.
2. Packaging converters.
3. Amenity formulators and fillers.
4. Kitting and logistics.
5. Hotel chains, airlines and distributors.
6. Guests.

Ming Fai is vertically integrated across steps 2 to 4, and through OS&E it also acts as a distributor at step 5. It buys commodity inputs whose price follows oil, and sells to concentrated, price-disciplined buyers. That combination explains why input-cost spikes squeeze its margin before prices can be reset.

Regulation: the single-use miniature is being legislated away

This is the most important industry-level force for a company whose core product is the small bottle.

• China. Shanghai required hotels to stop proactively providing six disposable items (toothbrushes, combs, bath scrubbers, razors, nail files, shoe polishers) from 1 July 2019. National plastic-pollution rules then required star-rated hotels to stop proactively providing single-use plastic items by the end of 2022, extended to all hotels, guesthouses and B&Bs by the end of 2025. In January 2024 Chinese consumer associations called on hotels to charge for disposable plastic items.
• California. AB 1162 banned small plastic toiletry bottles (under 6oz) in hotel rooms from January 2023 for large properties and January 2024 for smaller ones.
• New York State. Small bottles (under 12oz) were banned in hotels with 50 or more rooms from 1 January 2025 and in smaller hotels from 1 January 2026.
• European Union. The Packaging and Packaging Waste Regulation prohibits single-use packaging for cosmetic and toiletry products in the accommodation sector from 1 January 2030, regardless of material.
• Chains moved ahead of the law. Marriott committed in 2019 to replace miniatures with larger pump bottles, and IHG made a similar commitment the same year.

The effect on suppliers is not the end of demand. Guests still need shampoo. It is a change in format: fewer, larger containers, wall dispensers and refill supply chains, less packaging and printing value per room, and in China an outright fall in the number of free disposable items handed out. This is industry-wide. Section 8 covers what it means specifically for Ming Fai.

Import substitution and trade

Two dynamics matter. First, US tariffs on Chinese goods since 2025 have pushed US-bound consumer-goods production into Southeast Asia, and Cambodia has been a beneficiary. Second, Chinese amenity makers are pushing exports as domestic demand per room shrinks under the disposables rules. In practice, that is import competition in third markets.

Cyclicality

The category is moderately cyclical through occupancy and strongly cyclical through hotel construction:

• Replenishment amenities fall with occupancy in a downturn and recover with it. The 2020 pandemic was the extreme case, when demand all but disappeared for a year.
• OS&E follows hotel openings, which lag the real-estate and credit cycle by several years and fall harder.
• Input costs follow oil, so an oil shock squeezes margins regardless of demand.

Tailwinds and headwinds

Tailwinds:

• Continued travel growth and hotel construction in Asia, the Middle East and India.
• Brand-standard upgrading in mid-scale hotels.
• Tariff-driven sourcing shifts that favour non-China plants.
• Sustainability rules that reward suppliers able to deliver refill systems and certified materials.

Headwinds:

• Structural decline in the number of single-use units per room.
• Chinese overcapacity competing on price.
• Oil-linked input costs.
• Hotel procurement consolidation, which concentrates buying power.

7. Growth Triggers

Ming Fai's announcements are thin on specific forward guidance. It gives no capacity numbers, named customer wins or dated launches. The triggers below are what management has said is coming, ranked by potential impact.

• Shifting more hospitality orders to the Cambodian plant. The 1H2026 outlook commits the group to "strategically allocate orders to the Cambodia production base to leverage its geographic location and logistics advantages", serving Southeast Asian hotel markets and lowering the tariff burden on US-bound goods. This extends Cambodia from the health care line to the core amenity business. (1H2026 interim results, 25 Aug 2026. The Cambodia base and Southeast Asian opportunity were also cited in the 1H2025 interim report, 25 Aug 2025: repeated.)

• Completion of the health care production relocation to Cambodia. The customer-requested move from China to Cambodia (Section 3) disrupted 2025 output. With Cambodian lines running, management expects the segment to serve its North American customers from a tariff-advantaged origin. (Q3 2025 business update, 12 Nov 2025. Recovery visible in the Q1 2026 update, 8 May 2026, and the 1H2026 interim results, 25 Aug 2026.)

• OS&E growth from China's hotel construction and renovation recovery. Management tied OS&E growth to the recovery of China's hotel construction market and continues to position H-Square as the "total solution" for new properties. (1H2025 interim report, 25 Aug 2025. OS&E cited as a growth offset in the Q3 2025 business update, 12 Nov 2025: repeated.)

• Sustainable and ESG-compliant products. Management says it will keep investing in R&D for environmentally compliant products, raise environmental standards for products, source low-impact raw materials and cut energy emissions. The group targets carbon neutrality by FY2030. This is the product response to the format shift described in Section 6. (FY2025 annual report, April 2026. 1H2026 interim results, 25 Aug 2026: repeated.)

• Capturing global travel growth with flexible operations. Management says it will track global tourism trends and adjust operations quickly to geopolitical risk, positioning the group as "an outstanding international brand centred on travel supplies and personal care products". (1H2026 interim results, 25 Aug 2026. Similar language in the 1H2025 interim report, 25 Aug 2025: repeated.)

• New business opportunities. The board says it is "seeking new business opportunities" while monitoring macroeconomic and geopolitical risk. No specific opportunity has been named. (Q1 2026 business update, 8 May 2026.)

• Technology upgrades and supply-chain control. Management plans continued investment in technology upgrades, product quality and supply-chain management to respond to market change and cost pressure. (1H2026 interim results, 25 Aug 2026.)

8. Key Risks

8.1 Persistent margin squeeze in hospitality supplies

Mechanism. Ming Fai buys oil-linked inputs (resin, surfactants, freight) and sells to chains whose contract prices reset only at tender. When costs rise, it absorbs them. When Chinese rivals cut prices, it must match them or lose tenders. Both happened at once in 2025-2026. Management has given the same explanation in every results event since 1H2025, with the 1H2026 profit warning attributing the fall in profit to:

"increased manufacturing cost pressures borne by the Group leading to a decline in gross profit margin, the impact of external environmental volatility, and intense industry competition" (1H2026 profit warning, 11 August 2026; translated from the Chinese-language version of the announcement)

Calibration. High probability, moderate severity. This is not a temporary dual-plant effect if, as management keeps saying, competition is a cause. Unless Cambodia materially lowers unit costs, or input prices fall, the core segment may be structurally less profitable than in 2024. This risk has already materialised. The question is whether it is cyclical or permanent.

8.2 Structural decline of the single-use format

Mechanism. The regulations and chain policies covered in Section 6 cut the number of miniatures, kits and printed cartons per room. Ming Fai's integrated packaging and printing capability is worth less in a world of wall dispensers and 300ml refills. In China, the "not proactively provided" rules mean guests receive fewer disposable items. In Europe, the 2030 ban covers all single-use formats. If Ming Fai's dispenser and refill offering does not take the share that its miniatures lose, volume per room falls even as rooms grow.

Calibration. High probability, slow-moving, moderate to severe over five years. Its earlier effect is visible in the 2019-2022 collapse in China revenue (Section 2), although the pandemic dominated that period. The FY2025 annual report's emphasis on ESG-compliant R&D shows management sees it. Whether the product response is big enough is not disclosed.

8.3 Health care concentration and US trade policy

Mechanism. The health care segment sells about 97% into North America to what is very likely a small number of customers (Section 4). Its 2025 collapse shows that the segment's fortunes depend on the customer's sourcing decisions and on US tariff policy, neither of which Ming Fai controls. Moving to Cambodia solves today's China-tariff problem. But US tariff treatment of Southeast Asian origins has itself shifted since 2025, and rules targeting goods with Chinese-sourced inputs could narrow Cambodia's advantage. The same risk now applies to the hospitality orders being moved to Cambodia (Section 7).

Calibration. Moderate probability, moderate group-level severity. Health care is under a tenth of revenue, but it is the fastest-swinging line, and the tariff logic underpins the Cambodia strategy for the whole group.

8.4 Capital allocation drift into "new business opportunities"

Mechanism. The group's own history includes a cosmetics-retail acquisition (2010), a laundry venture (2010-2014) and a property-related episode that drew a public activist campaign (Section 1). The board's May 2026 statement that it is "seeking new business opportunities", at a time when the core is under margin pressure, raises the risk that cash is spent on unrelated ventures rather than on the core or on shareholders. The main shareholder who historically opposed this, David Webb, died in January 2026, and his stake now sits with his estate (Section 10).

Calibration. Low to moderate probability, moderate severity. Nothing specific has been announced, but the combination of a weaker core, a large cash balance and less outside pressure is the pattern in which past mistakes were made.

8.5 China hotel-capex exposure in OS&E

Mechanism. About three-quarters of OS&E revenue is in mainland China and depends on new hotel openings and renovations. These follow China's property and credit cycle, which remains fragile. A slowdown in openings would shrink the segment's order intake 12-18 months later. Because OS&E is the segment management currently relies on for growth, a slowdown would also remove the main offset to the pressure described in 8.1.

Calibration. Moderate probability, low to moderate severity at group level, since OS&E is about 12% of revenue.

8.6 Shareholder-register overhang and control

Mechanism. The founding family and executive directors hold a large minority (Section 10), and the Webb estate's 16% block will eventually be sold, distributed or transferred. A block of that size in a thinly traded stock can only be disposed of through a placement, a sale to the family or a whole-company transaction. Separately, a controlling holder with a large cash balance could pursue a privatisation on terms set by the controller.

Calibration. Moderate probability that something happens with the Webb stake within a few years. Severity depends entirely on the terms. This is a structural point, not a judgement about anyone's intentions.

9. Walk the Talk

Results events used: FY2023 annual results (March 2024); 1H2024 interim results (27 Aug 2024); FY2024 annual results (March 2025, with a positive profit alert on 7 Mar 2025); 1H2025 interim results (25 Aug 2025); FY2025 annual results (26 Mar 2026); 1H2026 interim results (25 Aug 2026). The quarterly business updates of November 2024, 12 November 2025 and 8 May 2026 are used as cross-checks. Ming Fai does not issue numerical guidance, so the promises tracked here are qualitative strategic commitments.

The margin promise that came undone. The FY2024 positive profit alert credited stronger profit to tighter cost control and "expanding sales of high-margin products". For one year that worked. Within six months, the 1H2025 interim report was explaining a lower hospitality margin by "macroeconomic instability, increased supply-chain pressure and intense industry competition". The same three causes then recurred in the November 2025 update, the March 2026 profit warning, the May 2026 update and the August 2026 profit warning. Management never presented the 2024 margin gain as a durable step-change. But its strategy statements keep listing cost control as the answer to a problem that has grown worse in each of the four reported periods since.

The Cambodia bet, delivered on someone else's timetable. Cambodia has featured in strategy statements since the plant opened in 2018. When the payoff came, it was not a planned ramp but a scramble: the November 2025 update attributed the health care slump to "operational disruption caused by customers requesting the relocation of certain production facilities from China to Cambodia in response to US tariff policy". The plant's existence let Ming Fai keep the business rather than lose it to a supplier already outside China, which vindicates building it seven years earlier. The 1H2026 rebound shows the move worked. But the episode also shows who sets the pace.

An accurate and prompt discloser. Ming Fai issues voluntary quarterly updates, which few Hong Kong small caps do, and warned the market before both of its 2026 profit declines, in March 2026 for FY2025 and in August 2026 for 1H2026. The warnings matched the results that followed. On disclosure, this management under-promises rather than surprises.

Assessment. This management is candid and timely about results. It flags bad news early and does not dress it up. Its strategic language is generic and repeated, cost control and flexible operations, with few measurable commitments, so there is little to hold it to and the one testable promise (margins) has not held since 2024. The record is that of a conservative operator that reports reality accurately but has not shown it can change that reality in the core segment.

10. Ownership, Governance and Shareholder Friendliness

Part 1: Ownership and control

According to MarketScreener's register of disclosed holdings (latest available data, 2025), the main holders are:

The Ching brothers together hold about 35%, and with Liu about 38%, from roughly 734 million shares in issue. There is one class of shares, with no dual-class structure, golden share or pyramid. For a minority shareholder, the structure means the founding family is the largest bloc but not above 50%. It can usually carry ordinary resolutions given typical turnout, while special resolutions and independent-shareholder votes on connected transactions still need outside support. With about 16% in an estate and about 38% with insiders, the real free float is below half the register, which helps explain thin trading.

Part 2: Governance

The board has nine members: five executive directors, one non-executive director and three independent non-executive directors. Three independents is exactly the one-third minimum under Hong Kong rules.

• The chairman, Ching Chi Fai, is the founder and largest holder, not independent.
• His son, Ching Tsun Wah, and his brother, Ching Chi Keung, are executive directors.
• The non-executive director, Chan Yim Ching, joined the group in 1995 and was an executive director from 2007 to 2015 (company website).
• One independent, Hung Kam Hung Allan, has served since 2007. That is well beyond the nine years after which Hong Kong's revised Corporate Governance Code treats independence as needing particular justification. His website biography records hotel-management experience, including as an executive director of Top Glory International Holdings from 1997 to 2001.
• The audit committee is chaired by independent director Kwong Tony Wan Kit, a certified public accountant who the company says is currently CFO of HKEX-listed Top Form International.

Other governance points:

• The auditor is PwC, and no qualified opinion was found.
• The company announced a connected transaction for the purchase of equipment in January 2024. The terms could not be read for this report.
• The share award scheme was amended in August 2026.
• No disclosure of insider share pledges was found.
• Executive pay is not visibly tied to published performance targets in the materials reviewed.

Overall, governance is typical of a founder-controlled Hong Kong small cap: family-dominated, with independents at the regulatory minimum, one of them long-tenured.

Part 3: Capital returns

Dividends. Over the last three financial years, total dividends were:

Dividends rose in FY2024 and were cut by 30% in FY2025, tracking profit. The 1H2026 interim was then reduced to HK2.5 cents from HK3.0 cents, the first interim cut in the current run. Dividends have been paid twice a year since 2023, after a single small payment in 2022. Payouts follow earnings, roughly half of profit in FY2025, rather than a progressive policy.

Buybacks and dilution. MoatMap's database records no buybacks in the roughly 90 days since 5 July 2026. For the earlier period, StockAnalysis data show a small repurchase effect in FY2023 (about 0.3% buyback yield) and none in FY2024, FY2025 or 2026 to date. No repurchase announcements on the exchange were found for the three-year window. Whether the FY2023 figure was cancelled repurchases or share-award-scheme trustee purchases could not be verified. The board holds the standard general mandate to repurchase up to 10% of shares, renewed at the May 2026 AGM, but has not used it. The share count has been broadly flat at about 734 million, with no visible option dilution. The exact three-year change could not be verified from the sources available.

Verdict: Returns Capital. Cash comes back almost entirely through dividends that follow earnings, paid twice a year, with no meaningful buybacks despite a standing mandate.

11. Insider Activities

MoatMap's database, which scrapes the gated HKEX Disclosure of Interests portal and is current to 2 October 2026, records no insider transactions in 3828.HK by directors or substantial shareholders in the 12 months to October 2026. That covers the founding family, the other executive directors and the 16.33% holder. The last disclosed change of note is outside the window: David Webb raised his stake slightly in June 2025, adding 431,000 shares at about HK$0.70 to bring it to 16.05% at the time, per AASTOCKS reporting of the HKEX filing. His death on 13 January 2026 has not, on the data available, been followed by any disclosed transfer or sale of the estate's holding. The read is neutral: insiders neither bought into the 2026 share-price weakness and profit warnings nor sold. The estate's eventual disposal remains the one known future event on the register (risk 8.6).

12. Scenarios

Bull case. Cambodia becomes a real cost and tariff advantage rather than a duplicate plant. The health care customer settles into steady Cambodian supply, hospitality orders for US and Southeast Asian accounts move there, and the overlap with Shenzhen ends. Oil-linked input costs ease and Chinese price competition stabilises, so the hospitality margin recovers towards its 2024 level. OS&E keeps compounding as China and Southeast Asia open upgraded hotels, cross-selling replenishment contracts to new properties. Ming Fai's refill and dispenser range wins tenders as chains convert ahead of Europe's 2030 ban and US state rules, turning the format shift from a volume threat into a share gain against Chinese rivals that cannot pass chain audits. The board resists diversification, dividends recover with earnings, and the Webb estate's block is placed with long-term holders. In three years the business is a steadier, more geographically balanced amenity and fit-out supplier with two plants and a defensible position with Asian chains.

Base case. Management delivers roughly what it has signalled: more orders move to Cambodia, OS&E keeps growing from a small base, and the health care line stays volatile but larger than at its 2025 low. The core hospitality margin does not recover to 2024 levels, because competition and input costs remain the stated headwinds and Section 9 shows cost control has not reversed them. Revenue grows modestly with travel and hotel openings, while single-use volume per room keeps shrinking, offset partly by refill formats. Disclosure stays prompt, strategy language stays generic, and dividends continue to track earnings at about half of profit. The company remains a conservatively financed, family-led supplier earning a thinner margin on a larger, more diverse revenue base, and the Webb stake is still a pending question.

Bear case. Risks 8.1 and 8.2 compound. Chinese makers keep undercutting on miniatures while chains accelerate the move to dispensers, so Ming Fai fights for a shrinking unit pool at falling prices. Risk 8.3 then strikes: US rules on Southeast Asian goods with Chinese inputs tighten, removing Cambodia's edge just as more hospitality volume has moved there, while the concentrated health care customer re-sources again. China's hotel pipeline stalls (8.5), so OS&E stops offsetting the core. Under pressure to find growth, the board spends cash on an unrelated venture (8.4), echoing 2010. The Webb estate's block is sold at a discount or into a family-led transaction on the controller's terms (8.6). Dividends fall with earnings, and the business becomes a sub-scale commodity amenity maker with two plants and no pricing power.